Bill Gates, the second-richest man in the world, is already backing an effort to build better ways to diagnose and track Alzheimer’s disease. Now, he's helped sign on the world's richest man to back the effort as well.
With new support from Amazon founder Jeff Bezos and other donors, the Diagnostic Accelerator "venture philanthropy" project at the Alzheimer's Drug Discovery Foundation (ADDF) is poised to name its first grantees in the near future and has begun taking applications for a second round of grants focused on fast-tracking digital tools for the disease and its related dementias.
Image: Bill Gates pointed to research into voice recordings gathered through the 70-year Framingham Heart Study that could one day lead to smartphone-based diagnostics for monitoring cognitive decline. (CC BY 2.0/Ben Fisher/GAVI Alliance)
